Startup ResVita Bio Targets Rare, Netherton Syndrome with a Bacterial Factory
Date: 01/14/2025
.png)
By Ron Leuty – Senior Reporter, San Francisco Business Times
Zargar as a postdoctoral fellow was on an academic track and looking for a job as he stress-tested an idea kicked around with mentor Jay Keasling, a pioneer in synthetic biology at UC Berkeley. What if, they thought, they could genetically engineer a bacteria to convert sugars in skin lotions into therapeutic proteins continuously pumped onto the skin's surface?
Are you a new parent?
We have information to help you navigate caring for your child with ichthyosis
Learn More
